Need to invest in a good place? Consult Paul Mampilly!

Stock market is a tricky market. Every day the market sees fluctuations in prices. People gain profit or loss in a split second decision. For example, if a person decided to keep his high-priced shares in the investment market, thinking tomorrow the price could go even higher, would face a loss if the prices of that particular shares were to drop the next day. Similarly, if a person decided that instead of pulling out his shares which were not giving him any kind of profit, he would keep the shares in the market just for one more day and would be extremely delighted if the prices of the shares were to go sky high. The bottom line is: No one knows what kind of fluctuations they might see in the stock market. No one except investment expert Paul Mampilly.

Paul Mampilly started his academic career by completing his BBA degree in Finance and Accounting from Montclair State University. After receiving his MBA Degree from Fordham Graduate School of Business, Paul Mampilly started his professional career in 1991 when he joined Bankers Trust as an Assistant Portfolio Manager. Because of his knowledge about when and where to invest during alarming situations, Paul moved forward by managing multimillion dollar accounts at Deutsche Bank and ING. It was in 2006, when he was recruited by Kinetics Asset Management. He was called for the job so he could manage the hedge fund of the organization. The firm was worth $6 billion. Under the clever leadership of Paul, the firm’s asset rose to a staggering $25 billion, in a very short time.

Paul Mampilly, now, works at Banyan Hill Publishing where he uses his investment expertise to help people in increasing their wealth. With a resume this strong, Paul Mampilly could have easily worked anywhere he wanted and could have earned a handsome salary, but he decided to leave Wall Street because he thought it only served a minority of people. After leaving the Wall Street, Paul started a newsletter. He wanted to serve a majority of people and through his investment newsletter; he now helps many people invest their money.

Hyland’s Introduces New Homeopathic Baby Oral Pain Relief Tablets

There are a number of reasons why your infant may be experiencing oral pain and discomfort beyond what’s caused by teething. Mouth abrasion or trauma may be caused if a baby in advertently bites the gums or lips. A canker sore may develop that causes pain. A throat infection may cause pain in the gums. Taste buds on the tongue may become inflamed.


For any issue with your baby’s mouth, including teething, gum bleeding and redness or irritation of the delicate tissues of the mouth, mothers can trust the new Hyland’s Homeopathic Baby Oral Pain Relief tablets. For more than 100 years, Hyland’s has been creating science-based homeopathic remedies designed to help improve the health and overall wellness of every member of the family. When it comes to choosing an over-the-counter brand of medication that has been produced using only the highest quality ingredients and the most strict standards of quality and purity, Hyland’s is recognized as the name to trust for a wide array of safe, natural and effective remedies.


With a new and completely different formula than their previous popular teething remedy, the new Hyland’s Homeopathic Baby Oral Pain Relief tablets give baby fast and gentle relief from a variety of mouth issues, including gum swelling and redness, and overall mouth irritation.


This natural formula has been created using a carefully selected blend of six natural ingredients, including arnica Montana and chamomilla. The result is easy to administer formula parents can use to quickly provide their infants with fast temporary relief from such symptoms of mouth discomfort as sore, sensitive and swelling gums and oral tissues.


Crying, irritable and fussing babies are a problem in the past when mothers reach for this new Hyland’s remedy that works quickly and safely without unwanted side effects to provide fast relief from oral pain.

Learn more about Paul Mampilly, top investor in the U.S

Many Americans are looking for channels of making money and getting financial freedom. There are different approaches that people are applying as they try to make their business endeavors relevant. Investing may not be the easiest of tasks, but if you are dedicated and committed, you can make some important investments that will create you some good returns. To be an investor, you need to be up to date with the happenings in the financial sector. You need to be very smart since this is a market that is followed by millions of people from all over the world. If you make the wrong decision, you might find yourself on the losing side.

Paul Mampilly is one of the brilliant investors who are ready to share investment tips with their followers. Paul Mampilly Has Struck Gold Again. Mampilly is keen on helping the average American to make investments which can help them create wealth. Before he started advising the average Americans, he was working as a hedge fund manager in the Wall Street. The reason he left the Wall Street was so that he could get a chance to interact with the ordinary Americans who would like to invest in the industry, but have no opportunity because they lack information.

Paul Mampilly is a graduate of the Fordham University. He has a master’s degree in business administration. He started his career in as an assistant portfolio manager for the Bankers Trust. He climbed the ladder quickly, and by 2006, he was a hedge fund manager, managing accounts worth billions. Paul Mampilly worked for kinetics Asset Management which had $6 billion in capital when he was joining. He helped it to create $25 billion by the time he was leaving. Even as he left the Wall Street, his reputation was intact. He was in a better position to succeed even away from the Wall Street since his skills were proven to be working.

Paul Mampilly finally left the Wall Street so that he could concentrate on educating the average investor. Since he left Wall Street, he has created the Profits Unlimited newsletter that he is using to change the industry. He believes everyone has a chance to access the right information regarding investments by reading his newsletter.

How Your Baby Can Benefit from Hyland’s Teething Tablets

Your baby will often have their first tooth erupt when they are between four and six months of age. While it can be an exciting time for you and your child, it can also mean a lot of pain and discomfort for them. The teeth are slowly pushing through the gums, which can cause a lot of inflammation and pain. Thankfully, there are lots of different products on the market specific to teething pain. Hyland’s makes a wonderful product known as Hyland’s Teething Tablets which are specifically designed for young babies who are going through the teething stage.


These Hyland’s tablets are specific for oral pain because they naturally take care of the inflammation and get rid of the pain associated with teeth erupting through the gums. The tablets are made with all-natural ingredients, which is what the brand is known for. The ingredients include chamomile, coffee extract and lactose to provide effective but natural pain relief that is non-addicting and ideal for babies as young as two to three months of age. The small tablets dissolve almost instantly on the baby’s tongue and there is no weird aftertaste which could result in a sick and unhappy baby.


Hyland’s has been around since the turn of the century and was founded in 1903. Their ingredients are based on old homeopathic recipes that have been collected and used for generations. These herbs work just as well, if not better, than some of the other products that you might have used in the past. When it comes to your grouchy teething baby, there is no better option than Hyland’s. Hyland’s works with some of the best in the medical and herbal fields to come up with products that are not only incredibly safe to take, but are also going to be very effective in relieving pain.

Dr. Ira Kirschenbaum Talks About The Changes In The Orthopedics Industry

Dr. Ira Kirschenbaum serves as the chairman of Orthopedics at Bronxcare Health System located in Bronx New York. He is a specialist in hip, shoulder, and knee replacements. Not too long ago he shared industry data regarding joint replacement implants. Dr. Ira Kirschenbaum gained his popularity by contributing to the creation of a minimally invasive knee replacement surgery. In the surgery he only replaces partial tissue instead of the whole knee.


What’s In The Data?

The data Dr. Ira Kirschenbaum released shows the changes that are happening in the orthopedics industry. Generic joint implants are becoming more popular as well as the use of 3D technology and robotics during surgery. Joints are still being affected by rheumatoid arthritis, post traumatic arthritis, and osteoarthritis. Joints can further be deteriorated by prior injuries and obesity. Unfortunately these types of issues have increased in volume over the past few years and so has the number of orthopedic surgeries.


The Market Is Growing

Back in 2017 the global joint replacement implant market was worth over $16.5 billion. The market is now heading towards over $20 billion by 2022. The 3.87% growth rate is happening as more aging people are living longer today. Another growth contributor is the continuously climbing obesity rate and the growing awareness of the joint replacement surgery as an option.


Most Popular Joint Replacement Surgery

Today the most popular procedure in orthopedic joint replacements is the knee. Last year knee replacements were over 50% of the surgeries completed in that area. The numbers are expected to climb by close to 5% by 2022. The growth in surgery numbers includes total and partial knee replacements. The new innovations in knee replacement surgery makes the option more and more appealing. Sports injuries lately have also contributed to the increase in surgery numbers. The North American orthopedic joint replacement market is the biggest across the globe.


About Dr. Ira Kirschenbaum

Dr. Kirschenbaum has been practicing for more than 27 years. He got his medical degree from Albert Einstein College of Medicine of Yeshiva University in 1984. He specializes in reconstruction orthopedics, joint replacement, and orthopedic surgery.

Genucel Offers Healthy, Natural Skin Repair and Anti-Aging Solutions

The Genucel line of cosmetic products by Chamonix help to target the issues responsible for the appearance of aging. The products are externally applied serums and creams, made with natural ingredients that help to shrink the bags under the eyes and reduce general eyelid puffiness, sagging and lines in 15 days or less.


Clinical testing of the active ingredient in Genucel proved its effectiveness for these purposes. The tests determined that improvement was possible within 15 days for 95 percent of the subjects in the study. Surprisingly, the tests used products with only a 1 percent concentration of Eyeseryl, but Genucel contains a two percent concentration of this beneficial ingredient.


Eyeseryl is a natural peptide. Chamonix uses the peptide along with plant stem cells, algae extract, and green tea extract in their product. Other active ingredients include hydrolyzed marine collagen and goji berry extract. The company carefully chose each ingredient based on its ability to improve skin texture and appearance.

Use of the line of Genucel products can help to make the eyes look brighter, younger and healthier. The skin becomes softer and smoother. The skin tone evens out with regular use for an overall youthful appearance. The Genucel line has an extensive list of effective ingredients that create a complete skin care solution. In this system, there are blends of antioxidants, vitamins B3, B6, and C as well as hyaluronic acid and CoQ10. Severe skin sagging and puffiness improves within two weeks, but the improvements in texture, tone, and lines are often immediately noticeable.


Chamonix designed these products to not only improve damaged skin but to also help to prevent future damage. The protection comes from the intense moisturizing effects and the antioxidants that hydrate as well as reduce free radical damage. The company does not use potentially health-risking parabens or mineral oil that can also clog pores and lead to breakouts.


GreenSky : 21st Century Lending

GreenSky has become a prominent name in the lending industry, and this financial technology company has provided loans to consumers who fall under certain fields. These fields just so happen to be solar, healthcare and home improvement. The economy has certainly benefited from this lending program as it has generated close to $5 billion between 2012 – 2016. GreenSky  is federally-insured, and it provides these loans to banks and merchants. Fintech, a conglomerate of startups and private businesses, is an innovative application process of the financial-services industry that offers end-to-end processing via the internet. GreenSky  is one of the startups that is thriving in this community despite being less prominent than Lending Club Corp and Social Finance Inc.

How Does The Business Model Work?

This particular company has been in business since 2006. One of the biggest differences with GreenSky is that it doesn’t use its own assets for making loans. GreenSky has actually partnered with other financial institutions to make these loans a reality. As of 2016, this partnership now includes up to 14 different financial institutions. The idea and concept are rather brilliant to some degree, and the program’s mobile app is connected to over 12,000 merchants that fall under the three categories above. To get a more in-depth understanding of how this business model is succeeding, Wikipedia has a full-disclosure of the program. Individual contractors and retailors such as Home Depot have all benefited from GreenSky ‘s mobile app.

What’s The Future Outlook?

GreenSky  brought in an estimated $325 million in 2017. Thanks to its huge success, the company added a multi-million dollar expansion at its Atlanta location that created up to 350 jobs. In total, GreenSky has over 900 employees, and its growth is expected to continue for many more years. What more could you ever ask for in a lending company?

Stream Energy: Fighting for Its Community

The adage goes that “actions speak louder than words”. For companies like Stream Energy, they want to prove how important the local community is to their overall development. “Dallas-Based Stream Energy Creates Stream Cares for Philanthropy” is an article that has taken the time to detail some of their recent philanthropy and their calculated decision to open a new philanthropic branch of their company which they have entitled Stream Cares. Stream Cares is an attempt by the Dallas-based energy company to make a real change in the landscape of Texas in Dallas. One of the ways that they hope to do this is by devoting more manpower to their philanthropic endeavors through Stream Cares.


The manpower is certainly going to be necessary when it comes to the philanthropic endeavors of Stream Cares and their larger companies Stream Energy. With the devastating effects still being felt from hurricane Harvey and the rising homeless population in Dallas, there is no time to waste trying to work out the logistics of a large philanthropic project. Stream Energy founded the new division because they wanted to be sure that they could address the needs of all the individuals within their beloved state of Texas. Those needs were only exacerbated by the devastation that was caused by hurricane Harvey. If homelessness was growing in Dallas before the hurricane then homelessness only worsened afterward. All over Texas, there was an influx of people who had been displaced. Stream Energy took the lead as one of the corporate entities that spearheaded the effort to help the people that were affected by the hurricane.


Stream Energy open their doors in 2005. They have experienced exponential growth since then. With the original intention of only servicing the Texas area, the company soon grew to encompass more than seven different states. This growth pattern shows that they have been successful in building a loyal customer base. Customers all over the nation utilize the services offered by this company because of the excellent work that they do. The philanthropy is a byproduct of the company that truly cares. This company will continue to care about the people in its community.

Madison Street Capital Nominated in 5 Categories for M&A Advisor Awards

PR Newswire recently published an article titled “Madison Street Capital Announced as Finalist for the 17th Annual M&A Advisor Awards”.

The article reveals how the global investment company was recently revealed as a finalist for the M&A Advisor Awards in the categories of Professional Services, M&A Deal of the Year, Boutique Investment Banking Firm of the Year, and Equity Financing of the Year. The Madison Street Capital reputation continues to grow as they gain recognition for their hard work and dedication.

The company has been chosen as one of the nominees to be evaluated by a panel of judges. CEO of Madison Street Capital, Charles Botchway reveals that it is incredible to be recognized by the M&A Advisor. Not only is it a revelation of their capabilities, but it also reveals the dedication of their team to serving their clients. The winners will be announced on November 6th in New York.

The awards were created in 2002 to help recognize the leading transactions, firms, and dealmakers. The awards are focused on rewarding creativity and ingenuity in the field.

Though the industry has transformed in the past 16 years, the firm helps recognize the contributions of the finalists to the industry. Read more: Madison Street Capital Names New Managing Director to Oversee Origination Team | Business Insider and Madison Street Capital | Crunchbase

M&A Advisor was created in 1998 to provide intelligence and insights on the M&A industry. For more than two decades they have created one of the leading networks of M&A professionals.

They created the M&A Advisor Awards to recognize the achievements of the top performers in the industry while also creating connections around the world. They are focused on bringing together leaders in accounting, investment banking, law, private equity, and finance to help them meet the challenges and opportunities occurring within the marketplace.

Madison Capital has helped hundreds of clients in different industries to reach their goals with excellence, leadership, and integrity. They provide international investment banking to both private and public businesses. Madison Street Capital is focused on responding to queries quickly because they understand that the business world moves quickly. To help their clients meet opportunities where the investors and the business owners benefit, they provide a detailed capitalization structure tailored to the client.

The Madison Capital methodology is steeped in expertise and experience in corporate financing. They focus on specialized financings, mergers and acquisitions, valuations, deal structuring and designing exit strategies.

They have offices located in North America, Africa, and Asia. The company has been recognized as one of the fastest growing investment banks for lower to middle market businesses.

They have won a variety of awards such as the 2015 Honoree for the NACVA’s 40 Under Forty Industry Mavericks Award, the 2017 M&A Advisor Awards Debt Financing Deal of the Year, the International Deal of the Year, the Annual Turn Around Award for Restructuring Deal of the Year, and the Industrials Deal of the Year.

Learn more about Madison Street Capital:

Sahm Adrangi on the Absurdity of KodakOne

Sahm Adrangi, head of Kerrisdale Capital, had quite a bit to say about Eastman Kodak Company’s (NYSE:KODK) image rights management platform called KodakOne. His thoughts about this 138-year old company were not at all favorable.

While Kodak’s stock doubled after they announced a blockchain and cryptocurrency licensing partnership, Sahm Adrangi asserts that nothing will be achieved by the use of blockchain as an image copyright platform.

Kerrisdale believes blockchain does not minimize the amount of resources necessary to prevent copyright infringement, nor does it lower the risk. Kodak has discussed paying photographers with KodakCoins, a cryptocurrency that would be used with KodakOne.

Sahm Adrangi argues that Kodak’s actions are a stock promotion and an attempt to take the focus off of their troubled financial position. Though blockchain is in fact a legitimate technology for some industries, Sahm Adrangi does not believe photo licensing and management is one of them.

Kerrisdale Capital called KodakCoin nonsensical as a way to pay photographers because it’s only marketed to accredited investors, which means only photographers with a net worth of $1 million or an annual income of $200k can participate in the ICO. While cryptocurrency will be used by speculators, it will not be used by many image buyers or photographers.

Kodak did not develop, nor do they own, any blockchain technology. KodakOne was developed by WENN Digital. Kodak is simply a licensor that will collect royalty payments when transactions are processed. This means that the success of KodakOne is tied to WENN Digital.

With rising debt and a negative cash flow, Adrangi believes Kodak’s management has failed its investors. After Chapter 11 bankruptcy in 2011, Kodak failed to resolve the issues that led to the Chapter 11 filing. Sahm Adrangi believes Kodak’s recent actions are an attempt to prevent a fall back into bankruptcy.

The above referenced issues, along with suspicious trading activities by Kodak shareholders, are just some of the reasons why Kerrisdale Capital has called the equity worthless.